v3.26.3
Stockholders’ Deficit (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2026
Jan. 06, 2026
Equity Option [Member]    
Subsidiary, Sale of Stock [Line Items]    
Weighted average remaining term 1 year 25 days  
Options intrinsic value $ 0  
2017 Equity Incentive Plan [Member]    
Subsidiary, Sale of Stock [Line Items]    
Number of shares authorized 200,000  
Number of shares available for grant 128,000  
Securities Purchase Agreement [Member]    
Subsidiary, Sale of Stock [Line Items]    
Stock issued new, shares   1,415,000
Total cash proceeds   $ 14,150